June 2025
NASCAR Driver Joey Gase Endorses RevitalVision
Joey Gase, NASCAR driver and co-owner of Emerling-Gase Motorsports, is championing RevitalVision’s clinically proven digital training therapies. Gase—who was diagnosed with keratoconus in 2020—is helping to raise awareness about the importance of early detection and treatment of related eye conditions, while advocating for proactive eye health.
Read more
April 2025
RevitalVision Wins Three First Place Awards at ASCRS 2025
Three First Place awards were given to RevitalVision clinical studies at ASCRS 2025, recognizing breakthroughs in Keratoconus and MF-IOL vision improvement.
Congratulations to Dr. Lionel Raj (2 awards) and Dr. Adi Einan-Lifshitz for presenting these outstanding, award-winning studies.
This achievement highlights the growing clinical impact of RevitalVision’s non-invasive, neuroplasticity-based vision therapy.
March 2025
New published study: Long-term efficacy of perceptual learning therapy in amblyopia: A 5-year follow-up study
This new study was just published in the Latin American Journal of Ophthalmology (LAJO) and is the first study to evaluate the long-term effect of RevitalVision on adult patients with amblyopia.
Read article
February 25
RevitalVision makes US debut with digital vision enhancement technology
Eyes On Eyecare magazine has featured RevitalVision’s U.S. debut!
Read more about our journey to innovate vision care.
Read article
December 24
RevitalVision featured on Healio – Improving vision in Keratoconus patients
The article highlights a recent study published in the American Journal of Ophthalmology, showcasing significant vision improvements in keratoconus patients using RevitalVision’s technology.
The study demonstrates how RevitalVision’s targeted vision training improves functional vision with a long-lasting effect in keratoconus patients who are intolerant to contact lenses and do not achieve good vision with spectacles.
